HARROW, INC. HROW
- TRIESENCE — Uveitis Approved
- TRIESENCE — Postoperative Ocular Inflammation Phase 3
- BYQLOVI — Postoperative Ocular Inflammation Approved
Home › Targets › glucocorticoid receptor
Companies with an active program directed at glucocorticoid receptor.